Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;8(19):1213.
doi: 10.21037/atm-20-4665.

Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition)

Affiliations
Review

Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition)

Zhiyi Zhang et al. Ann Transl Med. 2020 Oct.

Abstract

Osteoarthritis (OA) is a degenerative disease of middle-aged and elderly people, contributed a higher burden of disease in China and the world. In 2017, under the support of the Rheumatology and Immunology Expert Committee of the Cross-Strait Medical and Health Exchange Association. The objective was to develop an evidence-based diagnosis and treatment guideline for OA in China based on emerging new evidence. The guideline was registered at International Practice Guidelines Registry Platform (IPGRP-2018CN028). The grading of recommendations assessment, development and evaluation (GRADE) approach was used to rate the quality of evidence and the strength of recommendations, and the RIGHT (Reporting Items for Practice Guidelines in Healthcare) checklist was followed to report the guideline. The guideline provides recommendations for the OA diagnosis, disease risks monitoring and evaluate, treatment purpose and physical, medical and surgical interventions. This guideline is intended to serve as a tool for Chinese clinicians for the best decisions-making on diagnosis and treatment of OA.

Keywords: Osteoarthritis (OA); development and evaluation (GRADE); grading of recommendations assessment; guideline.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-4665). The authors have no conflicts of interest to declare.

References

    1. Dieppe PA, Lohmander LS. Pathogenesis and management of pain in osteoarthritis. Lancet 2005;365:965-73. 10.1016/S0140-6736(05)71086-2 - DOI - PubMed
    1. Glyn-Jones S, Palmer AJR, Agricola R, et al. Osteoarthritis. Lancet 2015;386:376-87. - PubMed
    1. Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014;73:1323-30. 10.1136/annrheumdis-2013-204763 - DOI - PubMed
    1. Tang X, Wang S, Zhan S, et al. The prevalence of symptomatic knee osteoarthritis in China: results from the China health and retirement longitudinal study. Arthritis Rheumatol 2016;68:648-53. 10.1002/art.39465 - DOI - PubMed
    1. Chinese Rheumatology Association . The guideline for diagnosis and treatment of osteoarthritis. Chin J Rheumatol 2010;14:416-9.